期刊
ANTIOXIDANTS
卷 10, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/antiox10081240
关键词
Entamoeba histolytica; auranofin; drug resistance; transcriptomics; redoxomics; thioredoxin reductase
资金
- Israel Science Foundation [260/16]
- US-Israel Binational Science Foundation [2015211]
- Niedersachsen program
- ISF-NRF program [3208/19]
The study demonstrates that Auranofin-adapted Entamoeba histolytica trophozoites exhibit impaired growth, increased sensitivity to oxidative and nitrosative stress, and reduced levels of oxidative products compared to acute AF-exposed trophozoites. Additionally, overexpression of the mammalian thioredoxin reductase does not protect the parasite against AF, indicating that it is not central to the adaptation mechanism.
Auranofin (AF), an antirheumatic agent, targets mammalian thioredoxin reductase (TrxR), an important enzyme controlling redox homeostasis. AF is also highly effective against a diversity of pathogenic bacteria and protozoan parasites. Here, we report on the resistance of the parasite Entamoeba histolytica to 2 mu M of AF that was acquired by gradual exposure of the parasite to an increasing amount of the drug. AF-adapted E. histolytica trophozoites (AFAT) have impaired growth and cytopathic activity, and are more sensitive to oxidative stress (OS), nitrosative stress (NS), and metronidazole (MNZ) than wild type (WT) trophozoites. Integrated transcriptomics and redoxomics analyses showed that many upregulated genes in AFAT, including genes encoding for dehydrogenase and cytoskeletal proteins, have their product oxidized in wild type trophozoites exposed to AF (acute AF trophozoites) but not in AFAT. We also showed that the level of reactive oxygen species (ROS) and oxidized proteins (OXs) in AFAT is lower than that in acute AF trophozoites. Overexpression of E. histolytica TrxR (EhTrxR) did not protect the parasite against AF, which suggests that EhTrxR is not central to the mechanism of adaptation to AF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据